ProCE Banner Activity

Pulling Back the Curtain: The Importance of Staging Fibrosis in Patients With Chronic Hepatitis B

Clinical Thought

For patients with chronic hepatitis B, accurate liver fibrosis staging is key for risk stratification and designing management strategies. Read my commentary on the available noninvasive tests for assessing liver fibrosis and learn what methods may best suit your patients.

Released: January 12, 2024

Expiration: January 11, 2025

Share

Faculty

Grace LH Wong

Grace LH Wong, MD

Professor
Gastroenterology and Hepatology
Assistant Dean (Learning Experience)
Director
CUHK Medical Data Analytics Centre (MDAC)
Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong, China

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Grace LH Wong, MD

Professor
Gastroenterology and Hepatology
Assistant Dean (Learning Experience)
Director
CUHK Medical Data Analytics Centre (MDAC)
Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong, China

Grace LH Wong, MD: consultant: Gilead Sciences, GSK, Janssen; researcher: Abbvie, Gilead Sciences; non-CME/CE services: Abbott, Abbvie, Bristol Myers Squibb, Echosens, Furui, Gilead Sciences, Janssen, Roche.